All news

This Aclaris Therapeutics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Alpha Vantage · Benzinga · · AI-summarised by FinFlash

Several top Wall Street analysts have downgraded their ratings for five major companies. Wedbush notably cut Aclaris Therapeutics, Inc. (NASDAQ:ACRS) from Outperform to Neutral, lowering its price target significantly. Other companies receiving downgrades include Stanley Black & Decker, Shoals Technologies Group, Tyson Foods, and IDACORP, with adjusted price targets reflecting the revised outlooks.

Read original source

SWK company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.